Design,synthesis and anti-tumor activity evaluation of quinoline derivatives as histone deacetylase 8 inhibitors
As a member of class Ⅰ histone deacetylase(HDACs),HDAC8 is an important anticancer drug target.Based on our previously developed pharmacophore model for the HDAC8 inhibitor,we designed and synthesized 13 quinoline acid derivatives as new HDAC8 inhibitors.Among them,the compound SDFZ-E2 and SDFZ-E3 exhibited good HDAC8 inhibitory activities and isoform selectivity.In cell experiments,the target compounds SDFZ-E2 and SDFZ-E3 showed better antiproliferation activities than the known HDAC8 selective inhibitor PCI-34051.In addition,the proposed binding mode of SDFZ-E2 was investigated using molecular docking and molecular dynamics simulation.This work is a new attempt to develop HDAC8 selective inhibitor using quinoline as the scaffold,and the active compounds could serve as lead compounds for further structural optimization.
quinoline derivativehistone deacetylase 8 inhibitoranti-tumor activitypharmacophore model
NETL
NSTL
万方数据
